Pardeep Nijhawan, Chief Executive Officer, 10% Owner at Edesa Biotech, Inc. (EDSA), bought 3,000 shares at $5.25 ($16K) on 2021-03-25, disclosed to the SEC on 2021-03-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| EDSA | BUY | 2026-03-05 | $43K | — | Filing → |
| EDSA | BUY | 2026-03-04 | $36K | — | Filing → |
| EDSA | BUY | 2026-03-03 | $6K | — | Filing → |